Cite
1815P Emergent circulating tumor DNA (ctDNA) variants and ctDNA burden dynamics with potential associations with talazoparib antitumor activity in TALAPRO-1.
MLA
Castro, E., et al. “1815P Emergent Circulating Tumor DNA (CtDNA) Variants and CtDNA Burden Dynamics with Potential Associations with Talazoparib Antitumor Activity in TALAPRO-1.” Annals of Oncology, vol. 34, Oct. 2023, pp. S983–84. EBSCOhost, https://doi.org/10.1016/j.annonc.2023.09.2763.
APA
Castro, E., Laird, D., Dorff, T., Zhao, S., van Oort, I. M., Gasparro, D., Calabro’, F., Pignata, S., Geczi, L., Barthelemy, P., Kilari, D., Hopkins, J. F., Chen, H.-C., Healy, C. G., Chelliserry, J., Scagliotti, G., de Bono, J. S., Mehra, N., & Fizazi, K. (2023). 1815P Emergent circulating tumor DNA (ctDNA) variants and ctDNA burden dynamics with potential associations with talazoparib antitumor activity in TALAPRO-1. Annals of Oncology, 34, S983–S984. https://doi.org/10.1016/j.annonc.2023.09.2763
Chicago
Castro, E., D. Laird, T. Dorff, S. Zhao, I.M. van Oort, D. Gasparro, F. Calabro’, et al. 2023. “1815P Emergent Circulating Tumor DNA (CtDNA) Variants and CtDNA Burden Dynamics with Potential Associations with Talazoparib Antitumor Activity in TALAPRO-1.” Annals of Oncology 34 (October): S983–84. doi:10.1016/j.annonc.2023.09.2763.